Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells
- PMID: 18849077
- PMCID: PMC2893544
- DOI: 10.1016/j.molimm.2008.08.278
Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells
Abstract
The autoimmune disease systemic lupus erythematosus (SLE) is characterized by loss of tolerance to nuclear antigens such as chromatin, DNA, and RNA. This focused autoreactivity is thought to arise from the ability of DNA or RNA specific B cells to receive dual signals from the BCR and TLR9 or TLR7, respectively. The Tec kinase Btk is necessary for the production of anti-DNA antibodies in several murine models of SLE. To assess the role of Btk in the fate of DNA reactive B cells, we generated Btk-/- mice carrying the 56R anti-DNA Ig transgene on the C57BL/6 background. dsDNA specific B cells were present in 56R.Btk-/- mice, although they were not preferentially localized to the marginal zone. These cells were able to proliferate in response to large CpG DNA containing fragments that require BCR-induced internalization to access TLR9. However, anti-DNA antibodies were not observed in the serum of 56R.Btk-/- mice. A transgene expressing a low level of Btk in B cells (Btk(lo)) restored anti-DNA IgM in these mice. This correlated with partial rescue of proliferative response to BCR engagement and TLR9-induced IL-10 secretion in Btk(lo) B cells. anti-DNA IgG was not observed in 56R.Btk(lo) mice, however. This was likely due, at least in part, to a role for Btk in controlling the expression of T-bet and AID in cells stimulated with CpG DNA. Thus, Btk is required for the initial loss of tolerance to DNA and the subsequent production of pathogenic autoantibodies once tolerance is breached.
Figures
Similar articles
-
B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.Autoimmunity. 2015 Feb;48(1):1-12. doi: 10.3109/08916934.2014.993027. Autoimmunity. 2015. PMID: 25536171 Free PMC article.
-
Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.Front Immunol. 2019 Jan 30;10:95. doi: 10.3389/fimmu.2019.00095. eCollection 2019. Front Immunol. 2019. PMID: 30761150 Free PMC article.
-
Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells.Eur J Immunol. 2010 Sep;40(9):2643-54. doi: 10.1002/eji.201040521. Eur J Immunol. 2010. PMID: 20623551
-
Emerging roles of TLR7 and TLR9 in murine SLE.J Autoimmun. 2009 Nov-Dec;33(3-4):231-8. doi: 10.1016/j.jaut.2009.10.001. Epub 2009 Oct 21. J Autoimmun. 2009. PMID: 19846276 Review.
-
The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.Expert Rev Clin Immunol. 2016 Jul;12(7):763-73. doi: 10.1586/1744666X.2016.1152888. Epub 2016 Mar 4. Expert Rev Clin Immunol. 2016. PMID: 26864273 Free PMC article. Review.
Cited by
-
Reply.Arthritis Rheumatol. 2017 Feb;69(2):475-477. doi: 10.1002/art.39957. Arthritis Rheumatol. 2017. PMID: 27748073 Free PMC article. No abstract available.
-
Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.Front Cell Dev Biol. 2021 Jun 4;9:668131. doi: 10.3389/fcell.2021.668131. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34150760 Free PMC article. Review.
-
Overexpression of Fkbp11, a feature of lupus B cells, leads to B cell tolerance breakdown and initiates plasma cell differentiation.Immun Inflamm Dis. 2015 Sep;3(3):265-79. doi: 10.1002/iid3.65. Epub 2015 Jun 18. Immun Inflamm Dis. 2015. PMID: 26417441 Free PMC article.
-
Single-cell-level protein analysis revealing the roles of autoantigen-reactive B lymphocytes in autoimmune disease and the murine model.Elife. 2021 Dec 2;10:e67209. doi: 10.7554/eLife.67209. Elife. 2021. PMID: 34854378 Free PMC article.
-
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.J Immunol. 2019 May 15;202(10):2888-2906. doi: 10.4049/jimmunol.1800583. Epub 2019 Apr 15. J Immunol. 2019. PMID: 30988116 Free PMC article.
References
-
- Balabanian K, Couderc J, Bouchet-Delbos L, Amara A, Berrebi D, Foussat A, Baleux F, Portier A, Durand-Gasselin I, Coffman RL, Galanaud P, Peuchmaur M, Emilie D. Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus. J. Immunol. 2003;170:3392–3400. - PubMed
-
- Bolland S, Pearse RN, Kurosaki T, Ravetch JV. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity. 1998;8:509–516. - PubMed
-
- Busconi L, Bauer JW, Tumang JR, Laws A, Perkins-Mesires K, Tabor AS, Lau C, Corley RB, Rothstein TL, Lund FE, Behrens TW, Marshak-Rothstein A. Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9. J. Immunol. 2007;179:7397–7405. - PubMed
-
- Cariappa A, Tang M, Parng C, Nebelitskiy E, Carroll M, Georgopoulos K, Pillai S. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity. 2001;14:603–615. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
